Profile
Margit Mahlapuu was the founder of ScandiCure AB, founded in 2016, holding the title of Chief Executive Officer.
Current jobs include Chief Executive Officer at Alexera AB, Chairman & Chief Executive Officer at Arexela AB, Chief Executive Officer at Alexer, Managing Director at Pergamum AB, Director & Chief Scientific Officer at Sixera Pharma AB, and Professor-Molecular Medicine at the University of Gothenburg.
Former jobs include Post Doctoral Fellow at AstraZeneca AB from 2001 to 2002, Project Manager-Research & Development at Biovitrum AB from 2005 to 2007, Project Leader at Arexis AB from 2002 to 2005, Chief Scientific Officer at Promore Pharma AB, and Chief Scientific Officer at PharmaSurgics In Sweden AB. Education includes a doctorate from the University of Gothenburg.
Margit Mahlapuu active positions
| Companies | Position | Start |
|---|---|---|
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products based on therapeutic peptides | Corporate Officer/Principal | - |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome | Chief Tech/Sci/R&D Officer | - |
Arexela AB
Arexela AB Miscellaneous Commercial ServicesCommercial Services Provides scientific and technical research & development services | Chief Executive Officer | - |
Alexera AB
Alexera AB Real Estate DevelopmentFinance Provides real estate services | Chief Executive Officer | - |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Axelera AB
Axelera AB Engineering & ConstructionIndustrial Services Provides engineering, technical and project management services and develops & markets e-Commerce systems | Chief Executive Officer | - |
Former positions of Margit Mahlapuu
| Companies | Position | End |
|---|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Corporate Officer/Principal | - |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01/01/2002 |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Margit Mahlapuu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Develops therapeutic peptides for the bioactive would care market | Health Technology |
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products based on therapeutic peptides | Health Technology |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome | Health Technology |
ScandiCure AB
ScandiCure AB Pharmaceuticals: MajorHealth Technology Develops anti-diabetic drug based on small molecule antagonists of a novel key mediator | Health Technology |
Arexela AB
Arexela AB Miscellaneous Commercial ServicesCommercial Services Provides scientific and technical research & development services | Commercial Services |
Alexera AB
Alexera AB Real Estate DevelopmentFinance Provides real estate services | Finance |
Axelera AB
Axelera AB Engineering & ConstructionIndustrial Services Provides engineering, technical and project management services and develops & markets e-Commerce systems | Industrial Services |
- Stock Market
- Insiders
- Margit Mahlapuu
















